New York State Common Retirement Fund
PRLD icon

New York State Common Retirement Fund’s Prelude Therapeutics PRLD Stock Holding History

New York State Common Retirement Fund’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.7K Buy
+14,200
New +$61.8K ﹤0.01% 2828
2025
Q2 		– Sell
-3,622
Closed -$2.78K – 3305
2025
Q1 		$2.78K Hold
3,622
– – ﹤0.01% 3146
2024
Q4 		$4.62K Hold
3,622
– – ﹤0.01% 3146
2024
Q3 		$7.5K Sell
3,622
-15,500
-81% -$71.8K ﹤0.01% 3125
2024
Q2 		$72.9K Sell
19,122
-1,000
-5% -$4.07K ﹤0.01% 2988
2024
Q1 		$95.4K Hold
20,122
– – ﹤0.01% 2760
2023
Q4 		$85.9K Sell
20,122
-27
-0.1% -$82 ﹤0.01% 2814
2023
Q3 		$62.3K Buy
20,149
+149
+0.7% +$559 ﹤0.01% 2938
2023
Q2 		$90K Buy
+20,000
New +$120K ﹤0.01% 2947
2022
Q3 		– Sell
-92
Closed – – 3411
2022
Q2 		$0 Sell
92
-4,900
-98% -$24.9K ﹤0.01% 3522
2022
Q1 		$34K Sell
4,992
-4,100
-45% -$37.5K ﹤0.01% 3237
2021
Q4 		$113K Sell
9,092
-17
-0.2% -$277 ﹤0.01% 3041
2021
Q3 		$285K Buy
9,109
+34
+0.4% +$1.1K ﹤0.01% 2747
2021
Q2 		$260K Buy
9,075
+75
+0.8% +$2.67K ﹤0.01% 2927
2021
Q1 		$390K Buy
9,000
+1,800
+25% +$119K ﹤0.01% 2555
2020
Q4 		$515K Buy
+7,200
New +$358K ﹤0.01% 2341

Other funds holding PRLD

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

New York State Common Retirement Fund's PRLD Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Prelude Therapeutics (PRLD) in Q2 2026: 14,200 shares worth $75.7K. The stake represents ﹤0.01% of the portfolio and ranks #2828 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in PRLD as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in PRLD in Q4 2020 and has held it in 16 quarters since. The position peaked at $515K in Q4 2020. 75 funds tracked by Wall St. Rank hold PRLD as of Q2 2026.

  • New York State Common Retirement Fund held 14,200 shares of Prelude Therapeutics worth $75.7K as of Q2 2026.
  • Prelude Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Prelude Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2828 holding.
  • New York State Common Retirement Fund first reported a position in Prelude Therapeutics in Q4 2020 and has held it in 16 quarters since.
  • New York State Common Retirement Fund's Prelude Therapeutics position peaked at $515K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.